id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1299014,d15869e2-bfcd-4dfa-8a89-eab28aa0fa78,Q3,DENNY MILLER ASSOCIATES,25328,CELL THERAPEUTICS,2012,third_quarter,PHA,European Union approval of US cancer drugs.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-15T13:55:42.557000-04:00
1299015,d15869e2-bfcd-4dfa-8a89-eab28aa0fa78,Q3,DENNY MILLER ASSOCIATES,25328,CELL THERAPEUTICS,2012,third_quarter,MED,"S. 3187, Food and Drug Administration Safety and Innovation Act of 2012, provisions relating to the approval of new drugs.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-15T13:55:42.557000-04:00